{"id":12877,"date":"2025-08-07T18:42:19","date_gmt":"2025-08-07T13:12:19","guid":{"rendered":"https:\/\/www.torusdigital.com\/toruscope\/?p=12877"},"modified":"2025-08-07T18:57:13","modified_gmt":"2025-08-07T13:27:13","slug":"star-imaging-path-lab-ipo-opens","status":"publish","type":"post","link":"https:\/\/www.torusdigital.com\/toruscope\/news\/star-imaging-path-lab-ipo-opens\/","title":{"rendered":"Star Imaging & Path Lab IPO Opens: Key Details Investors Shouldn\u2019t Miss"},"content":{"rendered":"

[vc_section el_id=”blog-inner-layout”][vc_row overlay_dotted=””][vc_column el_class=”blog_primary”][vc_row_inner][vc_column_inner][vc_column_text css=””]Star Imaging & Path Lab Limited is set to launch its Initial Public Offering (IPO), offering investors a chance to participate in the leading healthcare diagnostics sector. The company, which is NABL-accredited, offers a comprehensive suite of diagnostic services, including radiology, pathology, and cardiology, to individuals and institutions.\u00a0<\/span><\/p>\n

This article provides key details about the <\/span>Star Imaging & Path Lab IPO<\/span><\/a> for prospective investors.<\/span><\/p>\n

<\/span>About Star Imaging & Path Lab Ltd.<\/b><\/span><\/h2>\n

Founded in 2004, Star Imaging & Path Lab Limited operates a diagnostic testing network with a strong regional presence in Delhi, Uttar Pradesh, and Nashik. The company provides a wide range of services, including advanced imaging solutions like X-rays, CT scans, MRIs, ultrasounds, and a full spectrum of pathology tests such as haematology, microbiology, and histopathology. The business operates across B2C (individual customers), B2B (private hospitals), and B2G (public-private partnership with government) models. Its advanced diagnostic technology and integrated service model are among its core strengths.<\/span><\/p>\n

<\/span>Star Imaging & Path Lab IPO Details<\/b><\/span><\/h2>\n

The Star Imaging & Path Lab IPO is an SME IPO and a book-building issue aiming to raise \u20b969.47 crore. It consists of a fresh issue of 39.20 lakh shares (aggregating up to \u20b955.66 Cr) and an Offer for Sale (OFS) of 9.72 lakh shares (aggregating up to \u20b913.80 Cr). The IPO will be listed on the BSE SME platform.<\/span><\/p>\n

\"\"<\/a><\/p>\n

<\/span>Important IPO Timeline<\/b><\/span><\/h2>\n\n\n\n\n\n\n\n\n\n\n
Event<\/b><\/td>\nDate<\/b><\/td>\n<\/tr>\n
IPO Open Date<\/b><\/td>\nFri, Aug 8, 2025<\/span><\/td>\n<\/tr>\n
IPO Close Date<\/b><\/td>\nTue, Aug 12, 2025<\/span><\/td>\n<\/tr>\n
Tentative Allotment<\/b><\/td>\nWed, Aug 13, 2025<\/span><\/td>\n<\/tr>\n
Initiation of Refunds<\/b><\/td>\nThu, Aug 14, 2025<\/span><\/td>\n<\/tr>\n
Credit of Shares to Demat<\/b><\/td>\nThu, Aug 14, 2025<\/span><\/td>\n<\/tr>\n
Tentative Listing Date<\/b><\/td>\nMon, Aug 18, 2025<\/span><\/td>\n<\/tr>\n
Cut-off time for UPI mandate confirmation<\/b><\/td>\n5 PM on Aug 12, 2025<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/span>Key IPO Details<\/b><\/span><\/h2>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Event<\/b><\/td>\nDetails<\/b><\/td>\n<\/tr>\n
IPO Date<\/b><\/td>\nAugust 8, 2025 to August 12, 2025<\/span><\/td>\n<\/tr>\n
Listing Date<\/b><\/td>\n–<\/span><\/td>\n<\/tr>\n
Face Value<\/b><\/td>\n\u20b910 per share<\/span><\/td>\n<\/tr>\n
Issue Price Band<\/b><\/td>\n\u20b9135 to \u20b9142 per share<\/span><\/td>\n<\/tr>\n
Lot Size<\/b><\/td>\n1,000 Shares<\/span><\/td>\n<\/tr>\n
Sale Type<\/b><\/td>\nFresh Capital-cum-Offer for Sale<\/span><\/td>\n<\/tr>\n
Total Issue Size<\/b><\/td>\n48,92,000 shares (aggregating up to \u20b969.47 Cr)<\/span><\/td>\n<\/tr>\n
Reserved for Market Maker<\/b><\/td>\n4,80,000 shares (aggregating up to \u20b96.82 Cr)<\/span><\/td>\n<\/tr>\n
Fresh Issue (Ex Market Maker)<\/b><\/td>\n34,40,000 shares (aggregating up to \u20b948.85 Cr)<\/span><\/td>\n<\/tr>\n
Offer for Sale<\/b><\/td>\n9,72,000 shares of \u20b910 (aggregating up to \u20b913.80 Cr)<\/span><\/td>\n<\/tr>\n
Net Offered to Public<\/b><\/td>\n44,12,000 shares (aggregating up to \u20b962.65 Cr)<\/span><\/td>\n<\/tr>\n
Issue Type<\/b><\/td>\nBookbuilding IPO<\/span><\/td>\n<\/tr>\n
Listing At<\/b><\/td>\nBSE SME<\/span><\/td>\n<\/tr>\n
Shareholding (Pre-Issue)<\/b><\/td>\n1,35,00,000 shares<\/span><\/td>\n<\/tr>\n
Shareholding (Post-Issue)<\/b><\/td>\n1,74,20,000 shares<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/span>Lot Size of Star Imaging<\/b><\/span><\/h2>\n\n\n\n\n\n\n\n\n
Application<\/b><\/td>\nLots<\/b><\/td>\nShares<\/b><\/td>\nAmount<\/b><\/td>\n<\/tr>\n
Individual investors (Retail) (Min)<\/b><\/td>\n2<\/span><\/td>\n2,000.00<\/span><\/td>\n\u20b92,84,000<\/span><\/td>\n<\/tr>\n
Individual investors (Retail) (Max)<\/b><\/td>\n2<\/span><\/td>\n2,000.00<\/span><\/td>\n\u20b92,84,000<\/span><\/td>\n<\/tr>\n
S-HNI (Min)<\/b><\/td>\n3<\/span><\/td>\n3,000<\/span><\/td>\n\u20b94,26,000<\/span><\/td>\n<\/tr>\n
S-HNI (Max)<\/b><\/td>\n7<\/span><\/td>\n7,000.00<\/span><\/td>\n\u20b99,94,000<\/span><\/td>\n<\/tr>\n
B-HNI (Min)<\/b><\/td>\n8<\/span><\/td>\n8,000.00<\/span><\/td>\n\u20b911,36,000<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/span>Star Imaging & Path Lab Limited Financials<\/b><\/span><\/h2>\n

The company has shown consistent and strong financial growth. The total income for FY25 was \u20b983.79 crore, a notable increase from \u20b979.97 crore in FY24. Profit After Tax (PAT) also saw a substantial rise, from \u20b912.45 crore in FY24 to \u20b915.96 crore in FY25. This growth highlights the company’s robust operational performance and effective strategy in the diagnostic sector.<\/span><\/p>\n

<\/span>Key Performance Indicators (as of March 31, 2025)<\/b><\/span><\/h3>\n